Home » Newsletters » BioWorld Science

BioWorld Science

June 17, 2010

View Archived Issues

MerLion Pharmaceuticals claims new macrolides

Astellas reports last year's product highlights

GE Healthcare identifies novel contrast agents for X-ray-based diagnosis

Novel antiviral compounds disclosed by GlaxoSmithKline

ACADIA describes new muscarinic acetylcholine receptor agonists

Merck & Co. identifies novel PDE10A inhibitors

Promising data reported on house dust mite allergy therapies

Zolpidem improves limb dystonia

Pridopidine beneficial in patients with Huntington's disease

ExonHit and Genmab sign agreement on new potential breast cancer targets

AMRI completes acquisition of Hyaluron

MultiCell contracts CDSS to manage phase IIb MCT-125 trial

GPR17 antagonist ticagrelor shows preclinical promise to treat demyelinating conditions

Endocyte presents interim phase I data on FR-targeting conjugates in solid tumors

Idarubicin/busulphan improves outcome of autograft in patients with NPM1-mutant AML

SCH-900105 is safe and advances from phase I to phase II trial

Promega and CDI validate predictive stem cell-based cardiotoxicity assays

FoldRx achieves funds to market tafamidis meglumine

Anacor reports on phase IIb trial of AN-2728 in psoriasis

Galera to advance dismutase mimetics for prevention of oral mucositis

EC grants QPI-1002 orphan status for prevention of DGF

Biogen enrolls first patient in phase II combination trial of BG-12 in MS

Pieris begins phase I trial of anticalin PRS-050 in cancer

Inovio begins immunization in phase I trial of VGX-3400X universal flu vaccine

EMA approves update to bortezomib label for multiple myeloma

Tranzyme and Norgine to codevelop ulimorelin in Europe and other regions

Anacor's AN-3365 achieves proof of concept in collaboration with GSK

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...